SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015092
Filing Date
2022-04-21
Accepted
2022-04-21 16:31:23
Documents
9
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A hsto-def14a_20220601.htm DEF 14A 1053246
2 GRAPHIC gebbcolgapen000008.jpg GRAPHIC 535518
3 GRAPHIC gebbcolgapen000005.jpg GRAPHIC 489007
4 GRAPHIC gebbcolgapen000001.jpg GRAPHIC 6540
5 GRAPHIC gebbcolgapen000004.jpg GRAPHIC 33776
6 GRAPHIC gebbcolgapen000006.jpg GRAPHIC 535785
7 GRAPHIC gebbcolgapen000003.jpg GRAPHIC 6540
8 GRAPHIC gebbcolgapen000002.jpg GRAPHIC 33776
9 GRAPHIC gebbcolgapen000007.jpg GRAPHIC 389380
  Complete submission text file 0001564590-22-015092.txt   3851600
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36003 | Film No.: 22841865
SIC: 2834 Pharmaceutical Preparations